Suvretta Capital Management, LLC Sana Biotechnology, Inc. Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.8 - $4.55 $3.8 Million - $6.18 Million	-1,357,648 Reduced 45.81%	1,606,056 $6.55 Million
Q3 2023 Nov 14, 2023	BUY	$3.77 - $6.23 $3.2 Million - $5.29 Million	849,904 Added 40.21%	2,963,704 $11.5 Million
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $6.57 Million - $10.4 Million	2,113,800 New	2,113,800 $6.91 Million
Q3 2021 Nov 15, 2021	SELL	$16.29 - $25.88 $1.63 Million - $2.59 Million	-100,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.65 - $32.14 $9.45 Million - $18.2 Million	-567,500 Reduced 85.02%	100,000 $1.97 Million
Q1 2021 May 17, 2021	BUY	$23.04 - $43.5 $15.4 Million - $29 Million	667,500 New	667,500 $22.3 Million

176

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $569M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.